Abstract
Detoxification approaches are evolving from physical to biological to eliminate the toxins altogether. The current study was conducted to compare the impact of 2 newly developed toxin deactivators, Magnotox-alphaA (MTA) and Magnotox-alphaB (MTB) with a commercially available toxin binder, Mycofix PlusMTV INSIDE (MF) in alleviating the pernicious effects of aflatoxin B1 (AFB1) in laying hens. The treatments were: 1) negative control (NC; without AFB1), 2) positive control (PC; contaminated with 500 ppb AFB1), 3) MF (PC + 2 kg MF/ton feed), 4) MTA (PC + 2 kg MTA/ton feed), and 5) MTB (PC + 2 kg MTB/ton feed). Detoxifying bacteria revealed a substantial reduction of different toxins in vitro, in which 98.8, 94.5, and 73.3% degradation rates were achieved, respectively, for zearalenone (ZEN), patulin, and AFB1 in the first 1 h of exposure. The PC group had a sharp decline in egg production (EP; 68.83%) while MTB showed the superior EP (95.74%) followed by NC (90.66%), MF (86.57%), and MTA (82.08%; P ≤ 0.05). Egg weight (EW) was also observed to be inferior in PC group (53.80 g; P ≤ 0.05). Egg mass (EM) was higher in MTB (57.55 g) and NC (54.33 g) groups while PC produced the lowest (39.64 g; P ≤ 0.05). MTB and NC groups also demonstrated the best FCR, 1.62 and 1.68, respectively, and PC manifested the poorest FCR (1.98) with higher ADFI (P ≤ 0.05). MTB also produced a superior moisture content (MC; 82.11%) with inferior DM (17.89%) in ileum content (P ≤ 0.05). The greatest liver fat content was found in MF group (48.19%) and MTA yielded the superior serum β-carotene and Vit A. MDA level in yolk samples was influenced by treatments, rendering the highest level in PC group (P ≤ 0.05). Ileum microbiota and blood characteristics were also affected by treatments. In general, MTB proves to be a toxin-deactivator candidate with comparable results to that of commercially available toxin-binders.